(Q38867466)

English

Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial

scientific article published on 25 July 2017

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 September 2017

Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial (English)

1 reference

Europe PubMed Central

7 September 2017

phase I clinical trial

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Frank von Sonnenburg

14

object named as

Frank von Sonnenburg

0 references

Raphael Gottardo

7

object named as

Raphael Gottardo

1 reference

Europe PubMed Central

7 September 2017

Mariola Fotin-Mleczek

11

object named as

Mariola Fotin-Mleczek

1 reference

Europe PubMed Central

7 September 2017

12

object named as

Ingmar Hoerr

1 reference

Europe PubMed Central

7 September 2017

Ulrike Gnad-Vogt

2

object named as

Ulrike Gnad-Vogt

1 reference

Europe PubMed Central

7 September 2017

author name string

Martin Alberer

1

1 reference

Europe PubMed Central

7 September 2017

Henoch Sangjoon Hong

3

1 reference

Europe PubMed Central

7 September 2017

Keyvan Tadjalli Mehr

4

1 reference

Europe PubMed Central

7 September 2017

Linus Backert

5

1 reference

Europe PubMed Central

7 September 2017

Greg Finak

6

1 reference

Europe PubMed Central

7 September 2017

Mihai Alexandru Bica

8

1 reference

Europe PubMed Central

7 September 2017

Aurelio Garofano

9

1 reference

Europe PubMed Central

7 September 2017

Sven Dominik Koch

10

1 reference

Europe PubMed Central

7 September 2017

Ralf Clemens

13

1 reference

Europe PubMed Central

7 September 2017

language of work or name

0 references

publication date

25 July 2017

1 reference

Europe PubMed Central

7 September 2017

1 reference

Europe PubMed Central

7 September 2017

The contribution of vaccination to global health: past, present and future

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2931665-3

7 January 2021

based on heuristic

inferred from DOI database lookup

New Vaccines against Epidemic Infectious Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2931665-3

7 January 2021

based on heuristic

inferred from DOI database lookup

RNA-based vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2931665-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenicity and protective efficacy induced by self-amplifying mRNA vaccines encoding bacterial antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2931665-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2931665-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of the first phase I/II clinical vaccination trial with direct injection of mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2931665-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2931665-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2931665-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2931665-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2931665-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Polarization of immunity induced by direct injection of naked sequence-stabilized mRNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2931665-3

7 January 2021

based on heuristic

inferred from DOI database lookup

An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2931665-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Devices for intradermal vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2931665-3

7 January 2021

based on heuristic

inferred from DOI database lookup

SPICE: exploration and analysis of post-cytometric complex multivariate datasets

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2931665-3

7 January 2021

based on heuristic

inferred from DOI database lookup

COMPASS identifies T-cell subsets correlated with clinical outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2931665-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Needle-free jet injection for administration of influenza vaccine: a randomised non-inferiority trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2931665-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety, tolerability, and immunogenicity of inactivated trivalent seasonal influenza vaccine administered with a needle-free disposable-syringe jet injector

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2931665-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2931665-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized clinical trial in adults and newborns in South Africa to compare the safety and immunogenicity of bacille Calmette-Guérin (BCG) vaccine administration via a disposable-syringe jet injector to conventional technique with needle and syrin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2931665-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Intradermal immunization with novel plasmid DNA-coated nanoparticles via a needle-free injection device

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2931665-3

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA vaccine delivered by a needle-free injection device improves potency of priming for antibody and CD8+ T-cell responses after rAd5 boost in a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2931665-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2931665-3

7 January 2021

based on heuristic

inferred from DOI database lookup

CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2931665-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(17)31665-3

1 reference

Europe PubMed Central

7 September 2017

1 reference

Europe PubMed Central

7 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38867466&oldid=1792661542"